The objective of this study was to estimate the frequency of headache in patients with confirmed COVID-19 and characterize the phenotype of headache attributed to COVID-19, comparing patients depending on sex and the need for hospitalisation.
Author
Simon Lee
-
-
Breaking newsCOVID-19
Abnormal MRI findings of the orbital or visual pathways in patients with severe COVID-19: observations from the French multicenter COVID-19 cohort
August 2, 2021The aim of this study was to report orbital and visual pathways MRI findings in a nationwide multicenter cohort of patients with severe COVID-19. -
Breaking newsCOVID-19
Neurological and HEENT Manifestations of COVID-19: A Systematic Review and Meta-Analysis
August 2, 2021COVID-19 has been associated with various neurological and atypical HEENT (head/eyes/eyes/nose/throat) manifestations. In this systematic review and meta-analysis the authors sought to review the evidence for these manifestations. -
Executive PageEAN NewsFeatured Slider
Executive Page: Exciting Educational Opportunities this Autumn
August 1, 2021This year has so far been a busy one for everyone involved in education at EAN, with plenty of exciting new projects joining the traditional fixtures in our education calendar. As Chair of the EAN Education Committee, it is my pleasure to give you a brief update on some of our recent activities and to remind you about our brand new programmes with deadlines still open. -
Paper of the MonthEAN NewsFeatured Slider
Research Paper of the Month: Direct to Angiography vs Repeated Imaging Approaches in Transferred Patients Undergoing Endovascular Thrombectomy
August 1, 2021Our research paper of the month is a pooled retrospective non-randomised cohort study, evaluating the functional and safety outcomes of direct to angiography (DTA) treatment paradigm vs repeated imagingin the different treatment windows and on-call hours vs regular hours in patients undergoing thrombectomy. -
Paper of the MonthCOVID-19Featured Slider
Covid-19 Paper(s) of the Month: Two separate studies on vaccine effectiveness in England and Israel
August 1, 2021For August 2021, we have selected two COVID-19 papers of the month, investigating the effectiveness of the Covid-19 vaccines in England and Israel, respectively. -
Breaking newsCOVID-19
Posterior Reversible Encephalopathy Syndrome and brain haemorrhage as COVID-19 complication: a review of the available literature
July 30, 2021In this article the authors describe the case of a COVID-19 patient who developed bilateral occipital lobe haemorrhages suggestive of haemorrhagic PRES. -
Breaking newsCOVID-19
A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson’s disease. The ERCOPARK study
July 30, 2021In this article the authors aimed to investigate the consequences of the first COVID-19 lockdown (mid-March - mid-April 2020) on motor and non-motor symptoms (NMS) in a cohort of French people with Parkinson's disease (PwP). -
Breaking newsCOVID-19
Impact of COVID-19 on the quality of life of patients with neuromuscular disorders in the Lombardy area, Italy
July 30, 2021In this article the authors aimed to evaluate the effects of the COVID-19 pandemic on the quality of life (QoL) and perceived disease burden of this group of patients. -
Breaking newsCOVID-19
Olfactory bulb SARS-CoV-2 infection is not paralleled by the presence of virus in other central nervous system areas
July 30, 2021In this article the authors aimed to describe the neuropathological findings in SARS-CoV-2 infected patients who died during the COVID-19 pandemic, and define and quantify the presence of virus in selected areas showing pathological signs. -
Breaking newsCOVID-19
Treatment and Outcomes of Patients With Ischemic Stroke During COVID-19: An Analysis From Get With The Guidelines-Stroke
July 30, 2021In this study, the authors analyze the characteristics, evaluation, treatment, and in-hospital outcomes of patients presenting with acute ischemic stroke (AIS) pre-COVID-19 and during COVID-19. -
Breaking newsCOVID-19
COVID-19 and Parkinson’s disease: a casual association or a possible second hit in neurodegeneration?
July 30, 2021In this article the authors report two male patients, aged 45 and 67, who developed a classical form of PD approximately three months after a moderate COVID-19 infection with dyspnea, fever, anosmia and ageusia. -
In this review, the authors summarize the current knowledge on epidemiology, clinical manifestation, and pathophysiology of ischemic stroke in patients with COVID-19 to bridge the gap from bench to bedside and clinical practice during the most challenging global health crisis of the last decades.
-
Breaking newsCOVID-19
Safety of the BNT162b2 COVID-19 vaccine in Multiple Sclerosis: Early experience from a tertiary MS Center in Israel
July 30, 2021The purpose of this study was to report real-life safety data of the BNT162b2 COVID-19 vaccine in a cohort of MS patients. -
Breaking newsCOVID-19
Rapid Onset of Functional Tic-Like Behaviours in Young Adults during the COVID-19 Pandemic
July 30, 2021The authors compared clinical features of participants with Tourette Syndrome or Persistent Motor/Vocal Tic Disorder to participants with Rapid Onset Tic-Like Behaviours.
